Belite Bio (BLTE)
(Delayed Data from NSDQ)
$48.68 USD
+0.22 (0.45%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $47.65 -1.03 (-2.12%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.30 |
EPS Last Quarter | -0.31 |
Last EPS Surprise | -10.71% |
ABR | 1.00 |
Earnings ESP
|
-10.00% |
---|---|
Current Year | -1.19 |
Next Year | -0.53 |
EPS (TTM) | -1.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 50.00M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 50.00M |
Low Estimate | NA | NA | NA | 50.00M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.30 | -0.32 | -1.19 | -0.53 |
# of Estimates | 2 | 2 | 3 | 2 |
Most Recent Consensus | -0.33 | -0.36 | -1.15 | -1.16 |
High Estimate | -0.27 | -0.27 | -1.12 | 0.10 |
Low Estimate | -0.33 | -0.36 | -1.27 | -1.16 |
Year ago EPS | -0.40 | -0.25 | -1.19 | -1.19 |
Year over Year Growth Est. | 25.00% | -28.00% | 0.00% | 55.18% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 3 | 1 |
Down Last 60 Days | 1 | 1 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.30 | -0.32 | -1.19 | -0.53 |
7 Days Ago | -0.30 | -0.32 | -1.19 | -0.53 |
30 Days Ago | -0.27 | -0.28 | -1.08 | -0.52 |
60 Days Ago | -0.27 | -0.28 | -1.08 | -0.52 |
90 Days Ago | -0.27 | -0.28 | -1.08 | -0.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.33 | -0.36 | -1.19 | -1.16 |
Zacks Consensus Estimate | -0.30 | -0.32 | -1.19 | -0.53 |
Earnings ESP | -10.00% | -14.29% | 0.00% | -118.87% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.31 | -0.27 | -0.25 | -0.40 | NA |
Estimate | -0.28 | -0.34 | -0.36 | -0.31 | NA |
Difference | -0.03 | 0.07 | 0.11 | -0.09 | 0.02 |
Surprise | -10.71% | 20.59% | 30.56% | -29.03% | 2.85% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more